---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-004706"
form_type: "8-K"
ticker: "OTLC"
cik: "0000908259"
company_name: "Oncotelic Therapeutics, Inc."
filed_at: "2022-02-15T23:59:59+00:00"
generated_at: "2026-06-27T08:13:06.466880+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Oncotelic extends JH Darbie note maturity to Mar 2023; issues 33M warrants at $0.15

## Summary
- Maturity of convertible notes extended from March 31, 2022 to March 31, 2023 with all but one investor agreeing.
- Company to issue 33,000,066 Oncotelic warrants at an exercise price of $0.15 per common share.
- Each Unit holder receives 333,334 warrants per Unit purchased as consideration for the extension.
- Notes were originally issued in July 2020 as part of JH Darbie Financing units.

## SEC filing metadata
- accession: 0001493152-22-004706
- form_type: 8-K
- ticker: OTLC
- cik: 0000908259
- company_name: Oncotelic Therapeutics, Inc.
- filed_at: 2022-02-15T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03, 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/908259/000149315222004706/0001493152-22-004706-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/908259/000149315222004706/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-004706
- JSON: https://secwatch.observer/filing/0001493152-22-004706.json
- Plain text: https://secwatch.observer/filing/0001493152-22-004706.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.